How can the risk of extravasation be minimized during chemotherapy?

Minimizing the risk of extravasation during chemotherapy is crucial for patient safety and comfort. One effective approach is through the use of proper venous access techniques and close monitoring of the infusion. When venous access is appropriately established, it ensures that the chemotherapy is delivered directly into the bloodstream and reduces the chances of the medication leaking into surrounding tissues, which can cause significant damage. Regular monitoring during the infusion allows for the early detection of any adverse reactions or signs of extravasation, enabling prompt intervention.

In contrast, the other options do not adequately address the specific risks associated with intravenous chemotherapy administration. Oral chemotherapy agents eliminate the need for venous access altogether, but they are not applicable for all types of cancer treatments, which could lead to inconsistencies in care. Limiting the duration of treatment might reduce exposure time but does not directly tackle the risk of extravasation that can occur regardless of treatment length. Similarly, administering chemotherapy in a fasted state provides no protective benefit against extravasation, as this issue is related to the administration process rather than the patient's nutritional state. Thus, the focus on proper technique and monitoring stands as the most effective way to minimize the risk of extravasation.